AVR Long Call Strategy
AVR (Anteris Technologies Global Corp.), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.
Anteris Technologies Global Corp., a structural heart company, discovers, develops, and commercializes medical devices to enhance the quality of life for patients with aortic stenosis. Its lead product candidate is the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also devlops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. was incorporated in 1999 and is based in Toowong, Australia.
AVR (Anteris Technologies Global Corp.) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $240.2M, a beta of 0.59 versus the broader market, a 52-week range of 2.85-6.949, average daily share volume of 861K, a public-listing history dating back to 2024, approximately 136 full-time employees. These structural characteristics shape how AVR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.59 indicates AVR has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a long call on AVR?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current AVR snapshot
As of May 15, 2026, spot at $7.17, ATM IV 65.10%, IV rank 17.16%, expected move 18.66%. The long call on AVR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long call structure on AVR specifically: AVR IV at 65.10% is on the cheap side of its 1-year range, which favors premium-buying structures like a AVR long call, with a market-implied 1-standard-deviation move of approximately 18.66% (roughly $1.34 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated AVR expiries trade a higher absolute premium for lower per-day decay. Position sizing on AVR should anchor to the underlying notional of $7.17 per share and to the trader's directional view on AVR stock.
AVR long call setup
The AVR long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With AVR near $7.17, the first option leg uses a $7.17 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed AVR chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 AVR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $7.17 | N/A |
AVR long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
AVR long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on AVR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on AVR
Long calls on AVR express a bullish thesis with defined risk; traders use them ahead of AVR catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
AVR thesis for this long call
The market-implied 1-standard-deviation range for AVR extends from approximately $5.83 on the downside to $8.51 on the upside. A AVR long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current AVR IV rank near 17.16% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on AVR at 65.10%. As a Healthcare name, AVR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to AVR-specific events.
AVR long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. AVR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move AVR alongside the broader basket even when AVR-specific fundamentals are unchanged. Long-premium structures like a long call on AVR are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current AVR chain quotes before placing a trade.
Frequently asked questions
- What is a long call on AVR?
- A long call on AVR is the long call strategy applied to AVR (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With AVR stock trading near $7.17, the strikes shown on this page are snapped to the nearest listed AVR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are AVR long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the AVR long call priced from the end-of-day chain at a 30-day expiry (ATM IV 65.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a AVR long call?
- The breakeven for the AVR long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current AVR market-implied 1-standard-deviation expected move is approximately 18.66%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on AVR?
- Long calls on AVR express a bullish thesis with defined risk; traders use them ahead of AVR catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current AVR implied volatility affect this long call?
- AVR ATM IV is at 65.10% with IV rank near 17.16%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.